title: Rapid decrease in the prevalence of macrolide-resistant group A streptococci due to the appearance of two epidemic clones in Cantabria (Spain).
authors.forename: Maria A
authors.initials: MA
authors.lastname: Oliver
authors.forename: Celia
authors.initials: C
authors.lastname: García-Delafuente
authors.forename: Maria E
authors.initials: ME
authors.lastname: Cano
authors.forename: Flora
authors.initials: F
authors.lastname: Pérez-Hernández
authors.forename: Luis
authors.initials: L
authors.lastname: Martínez-Martínez
authors.forename: Sebastián
authors.initials: S
authors.lastname: Albertí
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002999:Clone Cells; D024881:Drug Resistance, Bacterial; D004363:Drug Utilization; D004917:Erythromycin / Q000494:pharmacology; D005838:Genotype; D006801:Humans; D018942:Macrolides / Q000494:pharmacology*; D010641:Phenotype; D013030:Spain / Q000453:epidemiology; D013290:Streptococcal Infections / Q000453:epidemiology* / Q000382:microbiology*; D013297:Streptococcus pyogenes / Q000187:drug effects* / Q000235:genetics
chemical_list: D000900:Anti-Bacterial Agents; D018942:Macrolides; D004917:Erythromycin